EXOD vs GSK · P/E 23, rev $121.6M vs P/E 13, $103.31B cap
Exodus Movement, Inc. (EXOD) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Exodus Movement, Inc. (EXOD) is a software - infrastructure company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported EXOD revenue for 2025-12-31 was $121.6M. Net income was -$11.4M. Revenue was up 4.5% from 2024-12-31 to 2025-12-31. EXOD currently screens at market cap $860.7M and trailing P/E 22.6.
GSK does not have a complete income-statement cache yet.
EXOD currently screens at market cap $860.7M and trailing P/E 22.6. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the EXOD and GSK stock pages for the full models.
Not investment advice.